Cerebral Hyperperfusion Syndrome (CHS) is an uncommon complication observed after intracranial angioplasty or stenting procedures. Given to the increasing use of new devices for intracranial angioplasty and stenting (INCS), in selected patients with high ischemic stroke risk, an equally increasing knowledge of complications related to these procedures is mandatory.
Case description: a 63-year-old man was diagnosed with an hyperperfusion syndrome after percutaneous angioplasty and stenting for severe symptomatic right internal carotid artery (ICA) siphon stenosis. After treatment he complained generalized seizures and respiratory failure. While conventional imaging did not demonstrate any acute brain lesions, Pseudo-Continuous Arterial Spin Labeling (PCASL) Perfusion MRI early documented right hemisphere blood flow increase suggestive for CHS.
Conclusions
Monitoring of perfusion changes after INCS could play an important a role in determining patients with high risk of CHS. ASL Perfusion MRI might be used for promptly, early diagnosis of CHS after treatment of severe intracranial artery stenosis.
PapanagiotouPRothCWalterS, et al.
Angiographic evidence of reperfusion injury after carotid artery stenting. J Am Coll Cardiol2012;
60: e7.
2.
Abou-CheblAYadavJSReginelliJP, et al.
Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Am Coll Cardiol2004;
43: 1596–1601.
ChangYKimBMBangOY, et al.
Rescue stenting for failed mechanical thrombectomy in acute ischemic stroke: a multicenter experience. Stroke2018;
49: 958–964.
5.
MeyersPMPhatourosCCHigashidaRT.Hyperperfusion syndrome after intracranial angioplasty and stent placement. Stroke2006;
37: 2210–2211.
6.
ChaudhrySAWatanabeMQureshiAI.The new standard for performance of intracranial angioplasty and stent placement after stenting versus aggressive medical therapy for intracranial arterial stenosis (SAMMPRIS) trial. AJNR Am J Neuroradiol2011;
32: E214.
7.
AlexanderMJZaunerAChaloupkaJC, et al.; WEAVE Trial Sites and Interventionalists.
WEAVE trial: final results in 152 on-Label patients. Stroke2019;
50: 889–894.
8.
MeyerLLeischnerHThomallaG, et al.
Stenting with acclino (flex) for symptomatic intracranial stenosis as secondary stroke prevention. J Neurointerv Surg2020;
12: 1127–1131.
9.
HayakawaMSugiuKYoshimuraS, et al.
Effectiveness of staged angioplasty for avoidance of cerebral hyperperfusion syndrome after carotid revascularization. J Neurosurg2019; 1–11.
10.
ZhangLDaiDLiZ, et al.
Risk factors for hyperperfusion-induced intracranial hemorrhage after carotid artery stenting in patients with symptomatic severe carotid stenosis evaluation. J NeuroIntervent Surg2019;
11: 474–478.
11.
KluytmansMvan der GrondJvan EverdingenKJ, et al.
Cerebral hemodynamics in relation to patterns of collateral flow. Stroke1999;
30: 1432–1439.
12.
GhumanMTsangACOKlostranecJM, et al.
Sentinel angiographic signs of cerebral hyperperfusion after angioplasty and stenting of intracranial atherosclerotic stenosis: a technical note. AJNR Am J Neuroradiol2019;
40: 1523–1525.
13.
TogashiSShimizuHSudaY.Utility of near-infrared spectroscopy monitoring in the management of hyperperfusion syndrome after intracranial carotid artery stenting. NMC Case Rep J2020;
7: 223–227.
14.
KarapanayiotidesTMeuliRDevuystG, et al.
Postcarotid endarterectomy hyperperfusion or reperfusion syndrome. Stroke2005;
36: 21–26.
BandoKSatohKMatsubaraS, et al.
Hyperperfusion phenomenon after percutaneous transluminal angioplasty for atherosclerotic stenosis of the intracranial vertebral artery. Case report. J Neurosurg2001;
94: 826–830.
17.
TeradaTTsuuraMMatsumotoH, et al.
Hemorrhagic complications after endovascular therapy for atherosclerotic intracranial arterial stenoses. Neurosurgery2006;
59: 310–318. discussion 310-318.
18.
LinY-HLiuH-M.Update on cerebral hyperperfusion syndrome. J Neurointerv Surg2020;
12: 788–793.
19.
BroziciMvan der ZwanAHillenB.Anatomy and functionality of leptomeningeal anastomoses: a review. Stroke2003;
34: 2750–2762.
20.
LinTLaiZZuoZ, et al.
ASL perfusion features and type of circle of willis as imaging markers for cerebral hyperperfusion after carotid revascularization: a preliminary study. Eur Radiol2019;
29: 2651–2658.
21.
EndoHFujimuraMSaitoA, et al.
Efficacy of arterial spin labeling magnetic resonance imaging with multiple post-labeling delays to predict postoperative cerebral hyperperfusion in carotid endarterectomy. Neurol Res 2021; 43: 252–258.
22.
FukudaTOgasawaraKKobayashiM, et al.
Prediction of cerebral hyperperfusion after carotid endarterectomy using cerebral blood volume measured by perfusion-weighted MR imaging compared with single-photon emission CT. AJNR Am J Neuroradiol2007;
28: 737–742.
23.
YoshieTUedaTTakadaT, et al.
Prediction of cerebral hyperperfusion syndrome after carotid artery stenting by CT perfusion imaging with acetazolamide challenge. Neuroradiology2016;
58: 253–259.
24.
DetreJAAlsopDC.Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. Eur J Radiol1999;
30: 115–124.
25.
ChngSMPetersenETZimineI, et al.
Territorial arterial spin labeling in the assessment of collateral circulation: comparison with digital subtraction angiography. Stroke2008;
39: 3248–3254.
26.
ZaharchukGDoHMMarksMP, et al.
Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke2011;
42: 2485–2491.
27.
ZaharchukG.Arterial spin label imaging of acute ischemic stroke and transient ischemic attack. Neuroimaging Clin N Am2011;
21: 285–301, x.
